# Oral Mucosal Vaccine for SARS-CoV2 Protection

Canonical: https://abierto.us/opportunities/75a50124c00002

- Solicitation number: 75A50124C00002
- Notice type: Award notice
- Status: Awarded to Vaxart Biosciences Inc. for $9,271,193.00
- Department: Department of Health and Human Services
- Agency: Office of Assistant Secretary for Preparedness and Response
- Contracting office: Aspr Administration for Strategic Preparedness and Response (75AN00)
- Place of performance: San Francisco, California
- County: San Francisco County (FIPS 06075). https://abierto.us/counties/san-francisco-county-ca-06075
- City: San Francisco. https://abierto.us/cities/san-francisco-ca-0667000
- First posted: January 13, 2024
- Last posted: January 13, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/c9e655fc3c514e6da562fa02948a4a6b/view

## Description

Oral Covid-19 XBB vaccine candidate as a/an tableted prophylactic vaccine for the treatment of SARS-CoV2. The scope of work for this contract encompasses the completion of the planning of and preparation for a phase 2b clinical trial.

## Award on USAspending

- Recipient: Vaxart Biosciences Inc. (UEI WS6UMD1QTBC9)
- Contract: 75A50124C00002, definitive contract
- Obligated: $9,271,191.00
- Competition: Full and Open Competition, 1 offers received
- Link: award number 75A50124C00002 equals the contract number; same sub-agency 7505 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75A50124C00002_7505_-NONE-_-NONE-/


## Publications

- January 13, 2024: Award notice. Notice c9e655fc3c514e6da562fa02948a4a6b. https://sam.gov/workspace/contract/opp/c9e655fc3c514e6da562fa02948a4a6b/view

## Points of contact

- richard hall, richard.hall@hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75a50124c00002.